Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD74 | P04233 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | CCR1 | P32246 | 2/20 | 0.40 |
| ▸ | CCR5 | P51681 | 2/20 | 0.40 |
| ▸ | CCR8 | P51685 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18904499 | 0.90 | CCR1 (0.44) | CD74MIFSMN1; SMN2LMNAKDM4E | |
| SCHEMBL18904464 | 0.88 | MEN1 (0.36) | CD74MIFSMN1; SMN2LMNAKDM4E | |
| SCHEMBL31300953 | 0.81 | KDM4E (0.57) | CD74MIFSMN1; SMN2LMNAKDM4E | |
| SCHEMBL13808799 | 0.81 | MEN1 (0.39) | CD74MIFSMN1; SMN2LMNAKDM4E | |
| SCHEMBL18902518 | 0.79 | CCR1 (0.47) | SMN1; SMN2LMNAKDM4EMAPTHTT | |
| SCHEMBL30960849 | 0.79 | CCR1 (0.47) | SMN1; SMN2LMNAKDM4EMAPTHTT | |
| SCHEMBL17899299 | 0.79 | CCR1 (0.47) | SMN1; SMN2LMNAKDM4EMAPTHTT | |
| SCHEMBL18904452 | 0.79 | CCR1 (0.47) | SMN1; SMN2LMNAKDM4EMAPTHTT | |
| SCHEMBL18905569 | 0.78 | MEN1 (0.32) | HSP90AA1CCR1CCR8NPC1RAB9A | |
| SCHEMBL17899331 | 0.78 | CCR1 (0.67) | CD74MIFSMN1; SMN2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10177317-B2 | Organic light emitting display device | LG DISPLAY CO., LTD. (KR) | 2019-01-08 | — | — | US | disclosed |
| US-20170155055-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2017-06-01 | — | — | US | disclosed |
| US-20170155055-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10177317-B2 | Organic light emitting display device | OCIAD2, L1CAM, OCIAD1 | CD74 1074/4885MIF 2030/4885SMN1; SMN2 3707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.